v3.26.3
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 288 $ 4,712 $ (18,682) $ (13,682)
Balance (in Shares) at Dec. 31, 2024 [1],[2] 2,875,000      
Compensation expense on transfer of shares to directors 108,750 108,750
Net income (loss) (134,620) (134,620)
Balance at Mar. 31, 2025 $ 288 113,462 (153,302) (39,552)
Balance (in Shares) at Mar. 31, 2025 [1],[2] 2,875,000      
Balance at Dec. 31, 2024 $ 288 4,712 (18,682) (13,682)
Balance (in Shares) at Dec. 31, 2024 [1],[2] 2,875,000      
Net income (loss)       815,689
Balance at Sep. 30, 2025 $ 326 (3,197,141) (3,196,815)
Balance (in Shares) at Sep. 30, 2025 [1],[2] 3,255,000      
Balance at Dec. 31, 2024 $ 288 4,712 (18,682) (13,682)
Balance (in Shares) at Dec. 31, 2024 [1],[2] 2,875,000      
Remeasurement for ordinary shares to redemption amount       (11,529,112)
Balance at Dec. 31, 2025 $ 326 (3,323,777) (3,323,451)
Balance (in Shares) at Dec. 31, 2025 [1],[2] 3,255,000      
Balance at Mar. 31, 2025 $ 288 113,462 (153,302) (39,552)
Balance (in Shares) at Mar. 31, 2025 [1],[2] 2,875,000      
Net income (loss) (62,889) (62,889)
Balance at Jun. 30, 2025 $ 288 113,462 (216,191) (102,441)
Balance (in Shares) at Jun. 30, 2025 [1],[2] 2,875,000      
Remeasurement for ordinary shares to redemption amount (6,401,805) (3,994,148) (10,395,953)
Sale of 380,000 Private Placement Units $ 38 3,799,962 3,800,000
Sale of 380,000 Private Placement Units (in Shares) [1],[2] 380,000      
Fair value of rights included in Public units 2,530,000 2,530,000
Allocated value of transaction costs to shares (168,834) (168,834)
Capital Contribution by Sponsor for issuance of founders shares to non-managing members (2,861,330) (2,861,330)
Issuance of Founders shares to non-managing members 2,861,330 2,861,330
Fair Value of over-allotment exercised 127,215 127,215
Net income (loss) 1,013,198 1,013,198
Balance at Sep. 30, 2025 $ 326 (3,197,141) (3,196,815)
Balance (in Shares) at Sep. 30, 2025 [1],[2] 3,255,000      
Balance at Dec. 31, 2025 $ 326 (3,323,777) (3,323,451)
Balance (in Shares) at Dec. 31, 2025 [1],[2] 3,255,000      
Remeasurement for ordinary shares to redemption amount (1,035,981) (1,035,981)
Net income (loss) 873,606 873,606
Balance at Mar. 31, 2026 $ 326 (3,486,152) (3,485,826)
Balance (in Shares) at Mar. 31, 2026 [1],[2] 3,255,000      
Balance at Dec. 31, 2025 $ 326 (3,323,777) (3,323,451)
Balance (in Shares) at Dec. 31, 2025 [1],[2] 3,255,000      
Net income (loss)       2,751,952
Balance at Sep. 30, 2026 $ 326 (3,746,100) (3,745,774)
Balance (in Shares) at Sep. 30, 2026 [1],[2] 3,255,000      
Balance at Mar. 31, 2026 $ 326 (3,486,152) (3,485,826)
Balance (in Shares) at Mar. 31, 2026 [1],[2] 3,255,000      
Remeasurement for ordinary shares to redemption amount (1,048,125) (1,048,125)
Net income (loss) 927,520 927,520
Balance at Jun. 30, 2026 $ 326 (3,606,757) (3,606,431)
Balance (in Shares) at Jun. 30, 2026 [1],[2] 3,255,000      
Remeasurement for ordinary shares to redemption amount (1,090,169) (1,090,169)
Net income (loss) 950,826 950,826
Balance at Sep. 30, 2026 $ 326 $ (3,746,100) $ (3,745,774)
Balance (in Shares) at Sep. 30, 2026 [1],[2] 3,255,000      
[1] On March 7, 2025, EBC (defined in Note 1) transferred 2,165,000 founder shares to the Sponsor (defined in Note 1) and directors. On June 30, 2025, the Sponsor transferred 105,000 ordinary shares to an independent party becoming a member of the Sponsor and EBC transferred 190,379 to EBCH Indigo LLC (Note 5).
[2] The three and nine months ended September 30, 2025 include an aggregate of up to 375,000 ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriters (Note 5 and 7). On July 11, 2025, the underwriters exercised their over-allotment option in full and as of such date, 375,000 shares were no longer subject to forfeiture.